Open — FY2027 Cycle 2 application receipt runs September 16 through December 8, 2026.
Atlas Opportunity Score 98/100
Verified September 29, 2026
Cancer Prevention and Research Institute of Texas (CPRIT)
CPRIT's FY 2027 Cycle 2 Cancer Screening and Early Detection RFA supports evidence-based breast, cervical, colorectal, liver and lung cancer screening for medically underserved and priority Texas populations. Applications open September 16, 2026 at 7:00 AM CT and close December 8, 2026 at 5:00 PM CT, with up to $1.5 million for new projects and up to $2.5 million for maintenance expansions.
Required next actionDefine the target Texas cancer burden and medically underserved/priority population, build the required evidence-based screening, diagnostic and treatment-navigation continuum, secure clinical and community partners, document any mobile/telehealth delivery and equipment needs, activate or verify CPRIT GMP accounts, and submit through the new Grants Management Platform between September 16, 2026 at 7:00 AM CT and December 8, 2026 at 5:00 PM CT.
Open — LOI-qualified applicants only
Atlas Opportunity Score 96/100
Verified September 29, 2026
Cancer Prevention and Research Institute of Texas (CPRIT)
CPRIT's FY 2027 Cycle 2 Texas Regional Excellence in Cancer Award offers up to $6 million over five years. The mandatory September 4, 2026 at 5:00 PM Central Time Letter of Intent gate has closed; only institutions that timely submitted an LOI and received CPRIT approval may proceed to the September 16-November 18, 2026 full application window.
Required next actionThe September 4, 2026 at 5:00 PM CT mandatory LOI deadline has passed. Do not initiate a new TREC pursuit. Proceed only if the institution timely submitted its LOI and CPRIT approved it. Qualified applicants should now prepare the full application for the September 16, 2026 at 7:00 AM CT opening and November 18, 2026 at 5:00 PM CT deadline, preserving the approved institutional theme, PI, shared-resource strategy, budget and required research-capacity elements.
Open — LOI-qualified applicants only
Atlas Opportunity Score 93/100
Verified September 29, 2026
Cancer Prevention and Research Institute of Texas (CPRIT)
CPRIT's FY 2027 Cycle 2 Texas Regional Training Award offers up to $2 million over five years for eligible regional institutions. The mandatory September 4, 2026 at 5:00 PM Central Time Letter of Intent gate has closed; only institutions that timely submitted an LOI and received CPRIT approval may proceed to the September 16-November 18, 2026 full application window.
Required next actionThe September 4, 2026 at 5:00 PM CT mandatory LOI deadline has passed. Do not initiate a new TRTA pursuit. Proceed only if the institution timely submitted its LOI and CPRIT approved it. Qualified applicants should now prepare the full application for the September 16, 2026 at 7:00 AM CT opening and November 18, 2026 at 5:00 PM CT deadline, preserving the approved training theme, PI, trainee structure, mentoring plan, budget and required regional cancer-workforce elements.
Active — current review cycle closes October 20, 2026
Atlas Opportunity Score 92/100
Verified October 1, 2026
Cancer Prevention and Research Institute of Texas (CPRIT)
CPRIT's FY 2027 Recruitment of Established Investigators program is open to Texas public and private institutions of higher education, including academic health institutions, seeking to recruit distinguished senior cancer researchers. Awards are up to $4 million over five years. The current FY27 review cycle closes October 20, 2026 at 11:59 PM Central Time, with later rolling cycles continuing through June 21, 2027 subject to available funding.
Required next actionIdentify a qualifying senior cancer investigator and institutional nominator; confirm current RFA/IFA eligibility; assemble investigator and institutional PDF materials; complete the nominator and Authorized Signing Official workflow; and submit by October 20, 2026 at 11:59 PM CT for the current review cycle. If missed, verify funding remains available before using a later FY27 recruitment cycle.
Open — FY27 Cycle 2 application receipt active through November 18, 2026
Atlas Opportunity Score 91/100
Verified September 29, 2026
Cancer Prevention and Research Institute of Texas (CPRIT)
CPRIT's FY 2027 Cycle 2 Clinical Trials Network Award provides up to $500,000 per year for up to five years to Texas lead institutions building networks that expand access to phase 2 and selected phase 3 cancer therapeutic trials. Applications open September 16, 2026 at 7:00 AM Central Time and close November 18, 2026 at 5:00 PM Central Time. A mandatory available-funds requirement equal to one-half of CPRIT funding applies before disbursement.
Required next actionReview the current CPRIT CTNA RFA and application materials, confirm lead-institution and network eligibility, define the participating cancer-care network and clinical-trials infrastructure, complete the required scientific and administrative materials, and submit during the FY2027 Cycle 2 application-receipt window ending November 18, 2026.
Active — current review cycle closes October 20, 2026
Atlas Opportunity Score 91/100
Verified October 1, 2026
Cancer Prevention and Research Institute of Texas (CPRIT)
CPRIT's FY 2027 Recruitment of Rising Stars program is open for Texas academic institutions recruiting outstanding mid-stage cancer investigators. Awards are up to $3 million over five years. The current FY27 review cycle closes October 20, 2026 at 11:59 PM Central Time, with later rolling cycles continuing through June 21, 2027 subject to available funding.
Required next actionIdentify a qualifying mid-stage cancer investigator and institutional nominator; confirm current RFA/IFA eligibility; assemble candidate and institutional PDF materials; complete the nominator and Authorized Signing Official workflow; and submit by October 20, 2026 at 11:59 PM CT for the current review cycle. If missed, verify funding remains available before using a later FY27 recruitment cycle.
Open — applications accepted September 16 through December 8, 2026
Atlas Opportunity Score 90/100
Verified October 7, 2026
Cancer Prevention and Research Institute of Texas (CPRIT)
CPRIT's newly released FY 2027 Cycle 2 dissemination RFA provides up to $450,000 over 36 months to scale successful CPRIT-funded cancer prevention and control interventions across Texas. Applications open September 16, 2026 at 7:00 AM CT and close December 8, 2026 at 5:00 PM CT. Eligibility is narrow: the dissemination project must stem from a qualifying completed CPRIT Prevention Program project or an ongoing expansion project.
Required next actionUse CPRIT's FY 2027 Cycle 2 Prevention materials and the new CPRIT Grant Management Platform. Confirm that the proposed project packages and disseminates a successful CPRIT-funded cancer prevention or control intervention, product, or other eligible output; verify applicant and project eligibility under the current RFA; prepare the required application materials in the GMP; and submit during the September 16 through December 8, 2026 application-receipt window.
Active — current review cycle closes October 20, 2026
Atlas Opportunity Score 90/100
Verified October 1, 2026
Cancer Prevention and Research Institute of Texas (CPRIT)
CPRIT's FY 2027 Recruitment of First-Time, Tenure-Track Faculty Members program is open for Texas academic institutions recruiting promising emerging cancer investigators into their first faculty appointments. Awards are up to $2 million over five years. The current FY27 review cycle closes October 20, 2026 at 11:59 PM Central Time, with later rolling cycles continuing through June 21, 2027 subject to available funding.
Required next actionConfirm the candidate fits the first-time tenure-track mechanism; designate the institutional nominator; verify current RFA/IFA requirements; assemble candidate and institutional PDF materials; complete the nominator and Authorized Signing Official workflow; and submit by October 20, 2026 at 11:59 PM CT for the current review cycle. If missed, verify funding remains available before using a later FY27 recruitment cycle.
